Media-OutReach Newswire Gene Solutions' Neoantigen Research Garners Prestigious Award, Paving the Way for Advanced Cancer Vaccines
Society Measles cases rise, with a third of children being treated in one hospital requiring ventilation
Media-OutReach Newswire AIM Vaccine has obtained clinical approval for two heavyweight products, creating new growth points for performance
Media-OutReach Newswire The global leader in rabies vaccines, the serum-free iterative rabies vaccine of AIM Vaccine has submitted a pre-application for marketing registration
IVD Medical Holding Limited (01931.HK): Officially launched the application for the US stablecoin license and accelerated the landing of the IVDNewCo Exchange ecosystem 1.